1-2 of 2
Michael Boe Møller
Close
Sort by
Journal Articles

Secondary cytogenetic abnormalities in core-binding factor AML harboring inv(16) vs t(8;21)

Se young Han, Krzysztof Mrózek, Jenna Voutsinas, Qian Wu, Elizabeth A. Morgan, Hanne Vestergaard, Robert Ohgami, Philip M. Kluin, Thomas Kielsgaard Kristensen, Sheeja Pullarkat, Michael Boe Møller, Ana-Iris Schiefer, Linda B. Baughn, Young Kim, David Czuchlewski, Jacobien R. Hilberink, Hans-Peter Horny, Tracy I. George, Michelle Dolan, Nam K. Ku, Cecilia Arana Yi, Vinod Pullarkat, Jessica Kohlschmidt, Amandeep Salhotra, Lori Soma, Clara D. Bloomfield, Dong Chen, Wolfgang R. Sperr, Guido Marcucci, Christina Cho, Cem Akin, Jason Gotlib, Sigurd Broesby-Olsen, Melissa Larson, Michael A. Linden, H. Joachim Deeg, Gregor Hoermann, Miguel-Angel Perales, Jason L. Hornick, Mark R. Litzow, Ryotaro Nakamura, Daniel Weisdorf, Gautam Borthakur, Gerwin Huls, Peter Valent, Celalettin Ustun, Cecilia C. S. Yeung
Journal: Blood Advances
Blood Adv (2021) 5 (10): 2481–2489.
https://doi.org/10.1182/bloodadvances.2020003605
Published: 2021
Includes: Supplemental data
Journal Articles

Proteomic profiling identifies outcome-predictive markers in patients with peripheral T-cell lymphoma, not otherwise specified

Clinical Trials & Observations
Maja Ludvigsen, Martin Bjerregård Pedersen, Kristina Lystlund Lauridsen, Tim Svenstrup Poulsen, Stephen Jacques Hamilton-Dutoit, Søren Besenbacher, Knud Bendix, Michael Boe Møller, Peter Nørgaard, Francesco d’Amore, Bent Honoré
Journal: Blood Advances
Blood Adv (2018) 2 (19): 2533–2542.
https://doi.org/10.1182/bloodadvances.2018019893
Published: 2018
Includes: Supplemental data